• Jury verdict in Delaware patent case brought by Beckman: noninfringement or invalidity on three of four asserted claims.
• One claim found infringed under doctrine of equivalents despite no literal infringement; past damages set at USD 56 million.
• Cytek plans post-verdict motions challenging the infringement finding and damages; appeal to the Federal Circuit remains possible.
• Verdict does not require changes to current products or operations; spectral flow cytometry products remain available worldwide.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cytek Biosciences Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608211635PRIMZONEFULLFEED9814393) on August 21, 2026, and is solely responsible for the information contained therein.